awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q46450905-D9458381-A04D-48E7-A653-215B55A0ABFB
Q46450905-D9458381-A04D-48E7-A653-215B55A0ABFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46450905-D9458381-A04D-48E7-A653-215B55A0ABFB
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
P2860
Q46450905-D9458381-A04D-48E7-A653-215B55A0ABFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46450905-D9458381-A04D-48E7-A653-215B55A0ABFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c320dcc4674cd3b503f5667efdf918d8be24e0a
P2860
ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.